Marc Frahm
Stock Analyst at TD Cowen
(0.10)
# 4,126
Out of 4,829 analysts
16
Total ratings
15.38%
Success rate
-33.45%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Marc Frahm
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SANA Sana Biotechnology | Upgrades: Buy | n/a | $2.00 | - | 2 | Jan 8, 2025 | |
| TBPH Theravance Biopharma | Maintains: Hold | $10 → $9 | $8.83 | +1.98% | 3 | Aug 6, 2024 | |
| INCY Incyte | Maintains: Buy | $88 → $80 | $60.84 | +31.49% | 3 | May 1, 2024 | |
| CGEM Cullinan Therapeutics | Initiates: Outperform | n/a | $7.85 | - | 1 | Jun 15, 2023 | |
| XLO Xilio Therapeutics | Initiates: Outperform | n/a | $0.73 | - | 1 | Nov 16, 2021 | |
| NUVL Nuvalent | Initiates: Outperform | n/a | $73.59 | - | 1 | Aug 23, 2021 | |
| ELEV Elevation Oncology | Initiates: Outperform | n/a | $0.36 | - | 1 | Jul 20, 2021 | |
| JANX Janux Therapeutics | Initiates: Outperform | n/a | $26.08 | - | 1 | Jul 6, 2021 | |
| DAWN Day One Biopharmaceuticals | Initiates: Outperform | n/a | $6.58 | - | 1 | Jun 21, 2021 | |
| INZY Inozyme Pharma | Initiates: Outperform | n/a | $1.18 | - | 1 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.75 | - | 1 | Feb 24, 2020 |
Sana Biotechnology
Jan 8, 2025
Upgrades: Buy
Price Target: n/a
Current: $2.00
Upside: -
Theravance Biopharma
Aug 6, 2024
Maintains: Hold
Price Target: $10 → $9
Current: $8.83
Upside: +1.98%
Incyte
May 1, 2024
Maintains: Buy
Price Target: $88 → $80
Current: $60.84
Upside: +31.49%
Cullinan Therapeutics
Jun 15, 2023
Initiates: Outperform
Price Target: n/a
Current: $7.85
Upside: -
Xilio Therapeutics
Nov 16, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.73
Upside: -
Nuvalent
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $73.59
Upside: -
Elevation Oncology
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.36
Upside: -
Janux Therapeutics
Jul 6, 2021
Initiates: Outperform
Price Target: n/a
Current: $26.08
Upside: -
Day One Biopharmaceuticals
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.58
Upside: -
Inozyme Pharma
Aug 18, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.18
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.75
Upside: -